Ultimately, thefindings emphasize the immune-suppressive properties of CBD and its potential use as an attractive therapeutic strategy for immunomodulation.’
Ultimately, thefindings emphasize the immune-suppressive properties of CBD and its potential use as an attractive therapeutic strategy for immunomodulation.’
Date: 09/01/20
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445536/
Tags: cannabidiol | CB1 and CB2 receptors | CBD | immune modulation | inflammasome | JAK/STAT | TRPV1
Contact details
LAYV B.V.
Panamalaan 2G
1019 AZ Amsterdam
📍LAYV CBD
hey@layv.co
Chamber of Commerce: 72846461
VAT: NL859258555B01
Products
© 2023 LAYV B.V.